Format

Send to

Choose Destination
Appl Biochem Biotechnol. 2016 Nov;180(5):841-851. Epub 2016 May 30.

Effect of Vanadyl Rosiglitazone, a New Insulin-Mimetic Vanadium Complexes, on Glucose Homeostasis of Diabetic Mice.

Jiang P1,2, Dong Z3, Ma B4, Ni Z1,2, Duan H1,2, Li X1,2, Wang B1,2, Ma X1,2, Wei Q1,2, Ji X1,2, Li M5,6.

Author information

1
Key Laboratory for Bioactive Materials of the Ministry of Education, Institute of Molecular Biology, College of Life Science, Nankai University, 300071, Tianjin, China.
2
State Key Laboratory of Medicinal Chemical Biology, Nankai University, 300071, Tianjin, China.
3
Tianjin No.1 High School, 300142, Tianjin, China.
4
Tianjin Children's Hospital, 300074, Tianjin, China.
5
Key Laboratory for Bioactive Materials of the Ministry of Education, Institute of Molecular Biology, College of Life Science, Nankai University, 300071, Tianjin, China. mgl@nankai.edu.cn.
6
State Key Laboratory of Medicinal Chemical Biology, Nankai University, 300071, Tianjin, China. mgl@nankai.edu.cn.

Abstract

Diabetes has been cited as the most challenging health problem in the twenty-first century. Accordingly, it is urgent to develop a new type of efficient and low-toxic antidiabetic medication. Since vanadium compounds have insulin-mimetic and potential hypoglycemic activities for type 1 and type 2 diabetes, a new trend has been developed using vanadium and organic ligands to form a new compound in order to increase the intestinal absorption and reduce the toxicity of vanadium compound. In the current investigation, a new organic vanadium compounds, vanadyl rosiglitazone, was synthesized and determined by infrared spectra. Vanadyl rosiglitazone and three other organic vanadium compounds were administered to the diabetic mice through oral administration for 5 weeks. The results of mouse model test indicated that vanadyl rosiglitazone could regulate the blood glucose level and relieve the symptoms of polydipsia, polyphagia, polyuria, and weight loss without side effects and was more effective than the other three organic vanadium compounds including vanadyl trehalose, vanadyl metformin, and vanadyl quercetin. The study indicated that vanadyl rosiglitazone presents insulin-mimetic activities, and it will be a good potential candidate for the development of a new type of oral drug for type 2 diabetes.

KEYWORDS:

Insulin-mimetic activities; Oral drug; Organic vanadium compounds; Type 2 diabetes; Vanadium; Vanadyl rosiglitazone

PMID:
27240663
DOI:
10.1007/s12010-016-2137-1
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center